TRAW
Traws Pharma, Inc.
Key Financials
Operating Income
$-142374000
↓ 601.4%
Revenue
$226000
0.0%
Net Income
$-166523000
↓ 778.8%
EPS (Diluted)
$-35.21
↓ 3812.2%
Total Assets
$25.0M
↑ 10.0%
Total Liabilities
$56.6M
↑ 371.2%
Cash & Equivalents
$20.6M
↓ 46.6%
Operating Cash Flow
$-29792000.00
↓ 66.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TRAW |
| Company Name | Traws Pharma, Inc. |
| CIK | 1130598 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 267-759-3680 |